Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T12:05:43.902Z.
Calculation as of: 2026-10-06T12:05:43.902Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b971b8577d60fbd13ce32004c11e36a47984c7f33f59c06b4987b60738766edb
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-05-07.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
PRICE/FCF RATIO AVG TTM
N/A
PRICE/FCF RATIO AVG 3Y
N/A
PRICE/FCF RATIO AVG 5Y
N/A
PRICE/FCF RATIO AVG 10Y
N/A
PRICE/FCF RATIO AVG 15Y
N/A
PRICE/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Black Diamond Therapeutics, Inc.
Market Cap
$111.17M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$108.39M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$114.24M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$106.23M
Price/FCF Ratio
N/A
TTM Avg
23.61
3Y Avg
13.61
5Y Avg
10.78
Market Cap
$117.43M
Price/FCF Ratio
N/A
TTM Avg
1.66
3Y Avg
1.66
5Y Avg
1.66
Market Cap
$118.02M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | $111.17M | N/A | N/A | N/A | N/A |
| Apyx Medical Corporation (APYX)vs › | $109.49M | N/A | N/A | N/A | N/A |
| Coya Therapeutics, Inc. (COYA)vs › | $113.77M | N/A | N/A | N/A | N/A |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.39M | N/A | N/A | N/A | N/A |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $114.24M | N/A | N/A | N/A | N/A |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.23M | N/A | 23.61 | 13.61 | 10.78 |
| Genelux Corporation (GNLX)vs › | $116.59M | N/A | N/A | N/A | N/A |
| Foghorn Therapeutics Inc. (FHTX)vs › | $117.43M | N/A | 1.66 | 1.66 | 1.66 |
| Caribou Biosciences, Inc. (CRBU)vs › | $118.02M | N/A | N/A | N/A | N/A |
| Definitive Healthcare Corp. (DH)vs › | $104.07M | 3.64 | 4.64 | 13.17 | 35.61 |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/FCF RATIO |
|---|---|
| 2026-05-07 | 5.24 |
| 2026-05-06 | 5.44 |
| 2026-05-05 | 5.53 |
| 2026-05-04 | 5.21 |
| 2026-05-01 | 5.01 |
| 2026-04-30 | 5.11 |
| 2026-04-29 | 4.95 |
| 2026-04-28 | 5.21 |
| 2026-04-27 | 5.63 |
| 2026-04-24 | 5.73 |
| 2026-04-23 | 5.98 |
| 2026-04-22 | 6.46 |
| 2026-04-21 | 6.07 |
| 2026-04-20 | 5.88 |
| 2026-04-17 | 5.90 |
| 2026-04-16 | 5.63 |
| 2026-04-15 | 5.53 |
| 2026-04-14 | 5.13 |
| 2026-04-13 | 5.24 |
| 2026-04-10 | 4.94 |
| 2026-04-09 | 4.97 |
| 2026-04-08 | 4.82 |
| 2026-04-07 | 4.72 |
| 2026-04-06 | 4.82 |
| 2026-04-02 | 4.61 |
| 2026-04-01 | 4.49 |
| 2026-03-31 | 4.11 |
| 2026-03-30 | 3.91 |
| 2026-03-27 | 3.91 |
| 2026-03-26 | 4.11 |
| 2026-03-25 | 4.22 |
| 2026-03-24 | 4.13 |
| 2026-03-23 | 4.14 |
| 2026-03-20 | 4.07 |
| 2026-03-19 | 4.14 |
| 2026-03-18 | 4.18 |
| 2026-03-17 | 4.30 |
| 2026-03-16 | 5.84 |
| 2026-03-13 | 5.65 |
| 2026-03-12 | 5.68 |
| 2026-03-11 | 6.00 |
| 2026-03-10 | 6.05 |
| 2026-03-09 | 5.81 |
| 2026-03-06 | 5.73 |
| 2026-03-05 | 5.47 |
| 2026-03-04 | 6.56 |
| 2026-03-03 | 6.13 |
| 2026-03-02 | 6.48 |
| 2026-02-27 | 6.59 |
| 2026-02-26 | 6.67 |
| 2026-02-25 | 6.91 |
| 2026-02-24 | 6.80 |
| 2026-02-23 | 6.43 |
| 2026-02-20 | 6.21 |
| 2026-02-19 | 6.13 |
| 2026-02-18 | 6.03 |
| 2026-02-17 | 5.95 |
| 2026-02-13 | 5.92 |
| 2026-02-12 | 5.84 |
| 2026-02-11 | 5.92 |
| 2026-02-10 | 6.08 |
| 2026-02-09 | 5.97 |
| 2026-02-06 | 6.03 |
| 2026-02-05 | 5.76 |
| 2026-02-04 | 6.37 |
| 2026-02-03 | 6.72 |
| 2026-02-02 | 6.77 |
| 2026-01-30 | 6.64 |
| 2026-01-29 | 7.01 |
| 2026-01-28 | 6.85 |
| 2026-01-27 | 6.91 |
| 2026-01-26 | 6.83 |
| 2026-01-23 | 6.96 |
| 2026-01-22 | 7.07 |
| 2026-01-21 | 6.85 |
| 2026-01-20 | 6.40 |
| 2026-01-16 | 6.83 |
| 2026-01-15 | 7.12 |
| 2026-01-14 | 7.44 |
| 2026-01-13 | 7.33 |
| 2026-01-12 | 7.04 |
| 2026-01-09 | 7.49 |
| 2026-01-08 | 7.41 |
| 2026-01-07 | 7.23 |
| 2026-01-06 | 6.93 |
| 2026-01-05 | 6.85 |
| 2026-01-02 | 6.64 |
| 2025-12-31 | 6.48 |
| 2025-12-30 | 6.64 |
| 2025-12-29 | 6.64 |
| 2025-12-26 | 6.91 |
| 2025-12-24 | 7.12 |
| 2025-12-23 | 6.80 |
| 2025-12-22 | 6.93 |
| 2025-12-19 | 6.77 |
| 2025-12-18 | 6.77 |
| 2025-12-17 | 6.91 |
| 2025-12-16 | 6.99 |
| 2025-12-15 | 7.07 |
| 2025-12-12 | 7.44 |
| 2025-12-11 | 7.36 |
| 2025-12-10 | 7.12 |
| 2025-12-09 | 7.23 |
| 2025-12-08 | 7.33 |
| 2025-12-05 | 7.12 |
| 2025-12-04 | 7.23 |
| 2025-12-03 | 7.17 |
| 2025-12-02 | 9.20 |
| 2025-12-01 | 10.05 |
| 2025-11-28 | 10.19 |
| 2025-11-26 | 10.08 |
| 2025-11-25 | 10.32 |
| 2025-11-24 | 10.27 |
| 2025-11-21 | 10.13 |
| 2025-11-20 | 10.16 |
| 2025-11-19 | 10.37 |
| 2025-11-18 | 10.59 |
| 2025-11-17 | 10.69 |
| 2025-11-14 | 10.69 |
| 2025-11-13 | 11.97 |
| 2025-11-12 | 12.99 |
| 2025-11-11 | 12.32 |
| 2025-11-10 | 11.63 |
| 2025-11-07 | 10.37 |
| 2025-11-06 | 12.65 |
| 2025-11-05 | 12.30 |
| 2025-11-04 | 11.50 |
| 2025-11-03 | 12.55 |
| 2025-10-31 | 12.30 |
| 2025-10-30 | 12.14 |
| 2025-10-29 | 12.14 |
| 2025-10-28 | 12.36 |
| 2025-10-27 | 12.55 |
| 2025-10-24 | 12.49 |
| 2025-10-23 | 12.33 |
| 2025-10-22 | 11.95 |
| 2025-10-21 | 12.59 |
| 2025-10-20 | 13.06 |
| 2025-10-17 | 12.74 |
| 2025-10-16 | 13.28 |
| 2025-10-15 | 13.19 |
| 2025-10-14 | 11.95 |
| 2025-10-13 | 12.08 |
| 2025-10-10 | 13.00 |
| 2025-10-09 | 13.73 |
| 2025-10-08 | 12.68 |
| 2025-10-07 | 12.43 |
| 2025-10-06 | 12.46 |
| 2025-10-03 | 12.36 |
| 2025-10-02 | 11.85 |
| 2025-10-01 | 11.82 |
| 2025-09-30 | 12.05 |
| 2025-09-29 | 11.85 |
| 2025-09-26 | 10.81 |
| 2025-09-25 | 9.88 |
| 2025-09-24 | 10.36 |
| 2025-09-23 | 10.07 |
| 2025-09-22 | 10.87 |
| 2025-09-19 | 10.42 |
| 2025-09-18 | 10.65 |
| 2025-09-17 | 10.04 |
| 2025-09-16 | 10.07 |
| 2025-09-15 | 10.14 |
| 2025-09-12 | 10.33 |
| 2025-09-11 | 10.71 |
| 2025-09-10 | 10.20 |
| 2025-09-09 | 10.33 |
| 2025-09-08 | 9.69 |
| 2025-09-05 | 9.34 |
| 2025-09-04 | 9.12 |
| 2025-09-03 | 9.15 |
| 2025-09-02 | 8.90 |
| 2025-08-29 | 8.74 |
| 2025-08-28 | 9.06 |
| 2025-08-27 | 9.12 |
| 2025-08-26 | 9.22 |
| 2025-08-25 | 9.12 |
| 2025-08-22 | 9.28 |
| 2025-08-21 | 8.61 |
| 2025-08-20 | 8.26 |
| 2025-08-19 | 8.42 |
| 2025-08-18 | 8.74 |
| 2025-08-15 | 8.77 |
| 2025-08-14 | 8.87 |
| 2025-08-13 | 8.80 |
| 2025-08-12 | 8.07 |
| 2025-08-11 | 7.34 |
| 2025-08-08 | 7.63 |
